Close Menu

NEW YORK – African genomics research company 54gene said on Tuesday that it has closed a $15 million Series A financing round.

The round was led by Adjuvant Capital, a life sciences fund backed by the International Finance Corporation, Novartis, and the Bill & Melinda Gates Foundation. Raba Capital, V8 Capital, and Ingressive Capital also participated in the round, while Y Combinator, Better Ventures, Fifty Years, KdT Ventures, Aera VC, and Pioneer Fund provided follow-on investment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.